Reports

Ideas That Generate Results

US Diabetes Market Outlook 2020

US Diabetes Market Outlook 2020

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Aug, 2015| No. of Pages : 85

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1000.00
CD-ROM Mail Delivery
US$ 1200.00
Hard Copy Mail Delivery
US$ 1200.00
Electronic Access - Multi-User License
US$ 1600.00

List of Figures:

Figure 3-1: Diabetes Market (Billion US$), 2013 & 2014
Figure 4-1: Prevalence of Diabetes (%), 2014 & 2030
Figure 4-2: Number of Diabetic Population (Million), 2014 & 2030
Figure 5-1: Total Healthcare Expenditure on Diabetes (Billion US$)-US vs. RoW, 2014
Figure 5-2: Cost per Person (US$) - US vs. RoW for People with Diabetes, 2014
Figure 6-1: Personal Disposable Income (Billion US$), 2008-2014
Figure 6-2: Population above 65 Years (Million), 2008-2014
Figure 7-1: Oral Diabetic Drugs Market (Billion US$), 2014-2020
Figure 7-2: Insulin Market (Billion US$), 2014-2020
Figure 7-3: Share of Key Players in Modern Insulin Market (FY 2013)
Figure 8-1: Insulin Pumps Market (Billion US$), 2014-2020
Figure 8-2: Shares of Key Players in US Insulin Pump Market (2013)
Figure 8-3: Insulin Pen Devices Market (Billion US$), 2014-2020
Figure 8-4: Insulin Syringes Market (Billion US$), 2014-2020
Figure 8-5: Insulin Jet Injectors Market (Billion US$), 2014-2020
Figure 9-1: Glucose Test Strips Market (Billion US$), 2014-2020
Figure 9-2: Lancets Market (Billion US$), 2014-2020
Figure 9-3: Blood Glucose Meter Market (Billion US$), 2014-2020
Figure 9-4: Continuous Blood Glucose Monitoring Market (Billion US$), 2014-2020
Figure 12-1: Pfizer - Breakup of Revenue by Geographies (%), 2014
Figure 12-2: GlaxoSmithKline - Breakup of Revenue by Geographies (%), 2014
Figure 12-3: Takeda - Breakup of Revenue by Geographies (%), 2014
Figure 12-4: Merck - Breakup of Revenue by Geographies (%), 2014
Figure 12-5: Novo Nordisk - Breakup of Revenue by Geographies (%), 2014
Figure 12-6: Eli Lilly - Breakup of Revenue by Geographies (%), 2014
Figure 12-7: Sanofi - Breakup of Revenue by Geographies (%), 2014
Figure 12-8: Medtronic Inc. - Breakup of Revenue by Geographies (%), 2014
Figure 12-9: Roche - Breakup of Revenue by Geographies (%), 2014
Figure 12-10: Bayer - Breakup of Revenue by Geographies (%), 2014
Figure 12-11: Abbott Laboratories - Breakup of Revenue by Geographies (%), 2014

List of Tables:

Table 4-1: Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2030
Table 12-1: Pfizer - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-2: GlaxoSmithKline - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-3: Takeda - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-4: Merck - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-5: Novo Nordisk - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-6: Eli Lilly - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-7: Sanofi - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-8: Medtronic Inc. - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-9: Roche - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-10: Bayer - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-11: Abbott Laboratories - Revenue by Business Segments (Billion US$), 2013 & 2014

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.